Trial Profile
A multicentric randomised controlled clinical trial of lamivudine,lamivudine plus adefovir and glycyrrhizin plus adefovir in HBV related decompensated cirrhosis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Jan 2020
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Glycyrrhizin (Primary) ; Lamivudine (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 02 Jul 2009 New trial record